Jump to content
Your browser is out of date. It has known security flaws and may not display all features of this websites. Learn how to update your browser[Close]

Restructuring


Roche to cut 350 IT jobs


Swiss pharmaceutical giant Roche is set to cut 350 IT jobs by the end of 2017, it has confirmed.

A spokesman told Reuters that 100 posts would be cut in Switzerland and another 100 in the United States, confirming a report by the Basler Zeitung newspaper. The remainder of the job cuts would be spread across several other countries, mostly in Europe.

At the same time, the Basel-based firm plans to add 300 jobs at its shared services centres, which include Madrid, Budapest, Warsaw and Kuala Lumpur. Roche employs around 91,000 people in over 100 countries, according to its annual report.

Roche recorded strong figures in the first three months of this year beating forecasts. Sales at the world's biggest maker of cancer drugs rose 4% to CHF12.4 billion ($12.87 billion).

Sales of its "big three" cancer medicines - Herceptin, Avastin and Rituxan that together account for more than a third of revenue - continued to climb.

The pharma giant aims to launch eight new medicines in the next three years as it seeks to mitigate a wave of patent expirations that will leave it vulnerable to biosimilar products starting in 2017. 

Sign up for our free newsletter and get the top stories delivered to your inbox.

swissinfo.ch with agencies

Copyright

All rights reserved. The content of the website by swissinfo.ch is copyrighted. It is intended for private use only. Any other use of the website content beyond the use stipulated above, particularly the distribution, modification, transmission, storage and copying requires prior written consent of swissinfo.ch. Should you be interested in any such use of the website content, please contact us via contact@swissinfo.ch.

As regards the use for private purposes, it is only permitted to use a hyperlink to specific content, and to place it on your own website or a website of third parties. The swissinfo.ch website content may only be embedded in an ad-free environment without any modifications. Specifically applying to all software, folders, data and their content provided for download by the swissinfo.ch website, a basic, non-exclusive and non-transferable license is granted that is restricted to the one-time downloading and saving of said data on private devices. All other rights remain the property of swissinfo.ch. In particular, any sale or commercial use of these data is prohibited.

×